SIRT2 has an overall positive effect in the liver, because it suppresses hepatic fibrosis [351] and steatosis [352], and it counteracts ROS generation and mitochondrial dysfunction to restore insulin sensitivity [353]. The gene discussed is SIRT2; the disease is steatosis.